chrisvoncsefalvay/vaers-outcomes huggingface dataset:
contracted COVID days before he was due to receive his 2nd dose of the Pfizer vaccine; contracted COVID days before he was due to receive his 2nd dose of the Pfizer vaccine; This is a spontaneous report from contactable consumer via Pfizer Sales Representative.  A 63-years-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  This healthy male contracted COVID days before he was due to receive his 2nd dose of the Pfizer vaccine. The outcome of the event was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Initial misuse report received from a healthcare professional on 19 July 2013. An 11-year-old patient was administered DAPTACEL instead of ADACEL. No adverse event was reported. List of documents held by sender: none.
01/27/2021 I woke up achy had a fever of 103.0, chills and I slept, this lasted 3 days, every time I woke I still had a fever and chills, but it did subside.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 30Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "sarcoidosis" (unspecified if ongoing). The patient's concomitant medications were not reported. No Known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (2023) negative; (2023) Negative; (2023) Positive, notes: Tested positive for covid after 2 days of testing negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient received treatment Paxlovid from 25Aug2023 to 29Aug2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Site of vaccine edematous, warm to touch, and redness.  Pt advised to use NSAID's and cool compresses to the affected area by physician.
24 hours after receiving Flublok, developed a rash all over.  Was taking Benadryl for rash.  No s/s of shortness of breath, anaplylaxis.
Started on the back of my calves as a rash and then developed into these crust like leisions.  This phenomenon spread to a variety of parts of my body over the last 6 months, from scalp to neck to face,  arms, buttock, back, forearms, back of hands, ankles and chest. It took several visits to my MD before she referred me to a dermatologist who diagnosed it as a Dermatologic Anomaly. Except for the Clobetasol Propionate for itching nothing else prescribed.
Passed out for about a minute or less; Seizure; fell; Shaking; This is a spontaneous report from a contactable pharmacist. A 30-year-old female patient received BNT162B2, intramuscular, administered in left arm on 09Aug2021 14:57 (Batch/Lot Number: FC3181; Expiration Date: Oct2021; NDC number: 59267-1000-01) at the age of 30 years old as dose 1, 0.3 ml single for COVID-19 immunisation. Medical history included rheumatoid arthritis and had a history of passing out. Family medical history relevant to adverse event was unknown. There were no concomitant medications. The patient previously took whooping cough vaccine in 2010. There were no other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s). On 09Aug2021, about 5 minutes after she was got the shot, the patient passed out for about a minute or less. She was in the waiting room. They had to call an ambulance. Upon the minute, the caller was awake, responding, had a good pulse. She was breathing, talking after passing out. The reporter explained that as far as what she witnessed, it was not serious. She was okay. When asked if event required a visit to - answered, "Emergency Room?" The patient was taken by ambulance, but she was not sure where it went. She is not sure if it was to the ER, but they took the patient out. The patient did mention she had not eaten all day. The caller didn't move the patient from where she passed out and fell. While she was on the ground, the patient mentioned she had a history of passing out. However, on the form she filled out, the patient responded 'no' to the question of "have you had any reaction to any previous vaccination including fainting or dizziness." A witness said she also thought the patient had a seizure because the patient was shaking. It's all subjective though. Outcome of events passed out was recovered on 09Aug2021, while other events was unknown. The reporter assessed the report as not serious and considered the relatedness of COVID-19 vaccine with passed out for about a minute or less as unknown.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal relationship between the events seizures, passed out and suspect drug BNT162B2 cannot be excluded The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Elevated Temp of 100.4 at 2:00 pm patient with red knot on right thigh and cranky. TX with Tylenol. Later in evening Temp at 102. Call to nurse hot line. Redness at right leg with red streak running up to mid abdomen. Tx with Motrin/Tylenol alternating every 3 hours 4/17/05. Rash on back, vomiting, cranky, rash spreading to head, trunk and legs. 04/19/05 looks like chicken pox referred to PP. Tx with Benadryl, pedialite. DX with allergic reaction to vaccine.
Herpes Zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 71 year old female patient. No information was provided regarding medical history, concurrent conditions, concomitant medications, drug reactions or allergies. In 2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, lot #, expiration date, route of administration and anatomical location were not provided) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced Herpes zoster. She was treated by a physician for the event. The outcome of the event herpes zoster was not reported. The reporter considered the event of herpes zoster to be related to zoster vaccine live (ZOSTAVAX).   Additional information has been requested.
pt recvd TTOX & w/in 24 hrs devel lt sided weakness; MRI of head showed a spot on brain; pt also had LP & other unsepcified tests; pts neurologist feels the sx are unrelated to vax r/o stroke or MS;
Child was given dose of FLULAVAL flu vaccine intended for > 18 yrs of age.
Pt reported that they are feeling "electrical signals" when they move, they were unable to sleep the night of the vaccine. They also stated that it feels like they are "stunned" when they move their head to the side. Pt appeared normal in no apparent distress besides the discomfort of the movements.
Severe fatigue, fever 101.6°, chills, night sweats that lasted for about 12 hours.   Fully recovered within 18 hours after onset of symptoms.
He died after being diagnosed with Lymphoma. Double hit , B cell.  He was fatigued a couple weeks after vaccine, fatigue worsened, then developed severe pain. Diagnosis to death was 11 days.
Symptoms: pulsitile tinnitus, severe fatigue, near syncopal episodes, abnormal bloodwork.   Primary care physician ordered numerous diagnostic?s and referred me to hematology oncology specialist. Repeat bloodwork still abnormal with no differential diagnosis yet.  Repeat bloodwork in four weeks to watch for changes.  Symptoms still persist.
Narrative: COVID infection following COVID vaccine series 02/18, Pfizer, dose #1 03/11, Pfizer, dose #2 09/27, Pfizer, dose #3 08/12 pt cc: chills, cough, headache, rhinorrhea exposure: unknown 08/13-08/12 pt symptoms continue 08/17 COVID swab, result: detected 08/17 SARS-COV-2 LINEAGE result: B.1.617.2 08/17 SARS-COV-2 CLADE result: 21A 08/23 clinically resolved
Shortness of breath, fatigue  Adverse event three days ago-visited primary care physician, referred to heart doctor.  Follow up testing scheduled but not yet performed
Received Moderna vaccines on 12/29/20, 1/25/21 Tested positive for COVID by PCR on 8/24/21 From Group Home  Admitted to Hospital on 8/24/21 to ICU
Child had immunizations. Grandmother called and said child was crying and had 105 degree fever at 0400 in morning. States she gave MOTRIN and fever down now to 101 degrees today. Denies any local reaction, seizure, lethargy. Didn't go to hospital.
Vaccine given 11-7-23. Pt started with facial swelling left side, cheeks, and lips on the morning of 11-9-23. Patient tried ice and benedril but that didnt help. He then made appt at Dr. office. no itching/not painful. Patient reports some swelling in the volar aspect of his left wrist, no nausea/no diarrhea/no rapid heart beat. Dx:  ang, edema from vaccine
pt recvd vax 28OCT92 & exp burning sensation @ time of vax; 30OCT92 2AM exp pain in the lt deltoid which radiated down arm to fingertips; exp no redness, no swelling, no bruising & no numbness;
Extra dose administered; weakness; fatigue; Inappropriate Schedule of vaccine administered; This case was reported by a nurse via sales rep and described the occurrence of weakness in a female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   Co-suspect products included Men ACWY-CRM NVS (Menveo) for prophylaxis and Men B NVS (Bexsero) for prophylaxis.   Previously administered products included Menveo (received 1st dose in 2015.). Concomitant products included Men B NVS (Bexsero).   On 15th July 2019, the patient received the 2nd dose of Menveo. On 16th August 2019, the patient received the 3rd dose of Menveo and the 2nd dose of Bexsero. On 15th July 2019, unknown after receiving Menveo, not applicable after receiving Menveo and Bexsero and an unknown time after receiving Bexsero, the patient experienced drug dose administration interval too long. In August 2019, the patient experienced weakness and fatigue. On 16th August 2019, the patient experienced extra dose administered. The patient was treated with steroids nos (Steroid Pack (Nos)). On an unknown date, the outcome of the weakness, fatigue, drug dose administration interval too long and extra dose administered were unknown.   It was unknown if the reporter considered the weakness and fatigue to be related to Menveo and Bexsero.  Additional case details were reported as follows: The age at vaccination was not reported. On 15th July 2019, the patient received 2nd dose of Menveo which led to lengthening of vaccination schedule. The patient received 3rd dose of Menveo by accident, which led to extra dose administered. The patients mom reported weakness and fatigue. The blood drawn to check for infection and gave patient steroid pack to reduce reaction to vaccines. The reporter gave permission to follow up.
After the first vaccine, the patient had a mild rash all over.  After the second vaccine, the patient stated she had a much more severe rash break out all over her body with red sores. This was a lasting event. She attempted to self-treat but had to go to doctor. She is now in a wound care program receiving care.
After getting the PENTACEL, the baby had a pitiful high pitched cry for about 75 minutes 3 hours after the vaccine. The doctor had told me to give him TYLENOL before, so I did. Then he slept for about 12 hours and I had to wake him up to breast feed him.
Dizziness; This is a spontaneous report received from a contactable consumer (patient). A 76-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6201), via an unspecified route of administration on Arm Left on 11Feb2021 as single dose for COVID-19 immunisation. The Patient's Medical history included asthma (since years ago) and lung cancer (but that is not a current condition, it was diagnosed Jan2017). The patient's concomitant medications were not reported. The patient historical vaccination included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL8982) and it was given on 21Jan2021 injected into her left arm for COVI-19 immunization at the age of 76-year-old. It was reported that, the consumer calling about the Pfizer COVID-19 vaccine who says she experienced dizziness for 11 days after her second shot in Feb2021. She says she saw the nurse practitioner one day at that office while she was having this problem. Caller says that on the 12th day her dizziness was gone, but she suffered 11 days with it. She says that she tried Antivert, different sized medication doses, it made her sleepy all day in addition to the vertigo and nauseousness, those were old pills in a pharmacy bottle without NDC/LOT/EXP on the label. She says she tried both 12.5mg dose and 25mg dose, one a day before sleep 24 hours apart. Caller says that the main reason she was calling is that she was concerned if there was a booster shot that might be required and she got it that this was gonna happen again if she has a booster shot in 6 months. Therapeutic measures were taken as a result of the event dizziness. The Outcome of the event was reported as unknown.  No follow-up attempts are possible. No further information is expected.
I had a high heart rate for about a week after the shot/my heart rate was way too high 121 and 124 BPM; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 42 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 27Jul2021 (Batch/Lot Number: EW0180) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included iron (IRON) taken for an unspecified indication, start and stop date were not reported; vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]) taken for an unspecified indication, start and stop date were not reported; loratadine (CLARITIN [LORATADINE]) taken for an unspecified indication, start and stop date were not reported; ascorbic acid, ergocalciferol, nicotinamide, retinol, riboflavin, thiamine hydrochloride (VITAMINS [ASCORBIC  ACID;ERGOCALCIFEROL;NICOTINAMIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]) fiber gummies taken for an unspecified indication, start and stop date were not reported. The patient previously took codeine and experienced drug hypersensitivity, bnt162b2 for covid-19 immunisation. The patient normally donate plasma twice a week and her normal heart rate is between 80-92. The cut-off to donate is under 100 BPM and was told she can not donate plasma. The patient experienced a high heart rate for about a week after the shot her heart rate was way too high 121 and 124 bpm causing heart rate increased on 29Jul2021 07:00 with outcome of recovered. The patient underwent lab tests and procedures which included heart rate high at 121 and 124 bpm.  Follow-Up (31Aug2021): Follow-up attempts are completed. No further information is expected.
dizziness; general head and body pain like when she had Covid in January 2021; her whole body inflammation; hand inflammation; feet inflammation; chills; general head and body pain like when she had Covid in January 2021; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Apr-2021 and was forwarded to Moderna on 08-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), PAIN (general head and body pain like when she had Covid in January 2021), INFLAMMATION (her whole body inflammation), INFLAMMATION (hand inflammation) and INFLAMMATION (feet inflammation) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Had Covid in January 2021) in January 2021.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced DIZZINESS (dizziness), PAIN (general head and body pain like when she had Covid in January 2021), INFLAMMATION (her whole body inflammation), INFLAMMATION (hand inflammation), INFLAMMATION (feet inflammation), CHILLS (chills) and HEADACHE (general head and body pain like when she had Covid in January 2021). At the time of the report, DIZZINESS (dizziness), PAIN (general head and body pain like when she had Covid in January 2021), INFLAMMATION (her whole body inflammation), INFLAMMATION (hand inflammation), INFLAMMATION (feet inflammation), CHILLS (chills) and HEADACHE (general head and body pain like when she had Covid in January 2021) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Blood pressure measurement: (High) elevated. On 04-Mar-2021, Heart rate: 110 (High) elevated heartrate.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications were provided No treatment medications were provided   This case was linked to US-MODERNATX, INC.-MOD-2021-071207 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-071207:Case for Second dose
Headache - lasted 2 days Severe Nausea- lasted ~6hours Muscle/joint pain - lasted ~1 day Fatigue - lasted 3 days Arm sore & swollen at injection site - still there  it's been 4 days  Face numbness lasted 5 minutes ~14 hours after injection
Dizziness grade 1; Vertigo grade 1; This is a spontaneous report from a contactable physician, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an intramuscular route of administration in the left arm on 14Mar2021 at 16:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had a known allergy to iodine contrast. The patient did not receive any medication within two weeks of the vaccination. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 14Mar2021 at 16:30, the patient experienced vertigo (CTCAE v 4.03 grade 1) and dizziness (CTCAE v 4.03 grade 1). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events vertigo (CTCAE v 4.03 grade 1) and dizziness (CTCAE v 4.03 grade 1) was resolved on an unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Patient received a Tdap for ages 7 and older instead of the Dtap recommended for ages 6 and under.
At 3:45 PM patient reported "I have itchiness all over." Patient was administered 50 mg Benadryl. At 3:50 PM the following vitals were taken BP 98/60, O2 92%, Pulse 57.  Pulse O2 remained at 92% until the patient left the clinic. By 4:15 PM the patient sated she no longer at itching and left the clinic.
Pt had a seizure on 10/22/01, the day of required vaccines. It lasted 20 minutes.
patient received Infanrix instead of Boostrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 12-year-old female patient who received DTPa (Infanrix) (batch number 9R2D7, expiry date 23-MAY-2025) for prophylaxis.   On 12-OCT-2023, the patient received Infanrix. On 12-OCT-2023, an unknown time after receiving Infanrix, the patient experienced wrong vaccine administered (Verbatim: patient received Infanrix instead of Boostrix). The outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 12-OCT-2023 A nurse reported that a patient received Infanrix instead of Boostrix, which led to wrong vaccine administered. The Vaccine Administration Facility is the same as Primary Reporter. The reporter consented to follow up.
Every problem I have was intensified, back, neck,dry eyes  were painful.  I started getting facial pain - short sharp pains several times a day and in my right ear.. New back pain, Burning in entire upper body & left breast pain.  I had a normal yearly mammogram  shortly after my vaccine o 03/09,  On 03/26 I went to my GBYN practice for a breast exam because of the breast pain.  They asked if I had had a vaccine recently and on what side.  The pain was on the same side.  I was told I had a swollen lymph  node and it would go back to normal 4-6 weeks after my 2nd shot which was 04/03.  It did not. It lasted over 6 and 1/2 months after which the pain started to lessen and I would have several days and then a couple of #18 weeks of no pain.  Then I would have only a little discomfort once in awhile.
Patient says he developed large urticaria within 24 hours of the vaccination. He can not attribute the hives to anything else so he believes it was from the vaccination. He took a course of prednisone to treat the hives. He did not have any other reactions or symptoms.
The day after, it felt like I had the flu and a lot of joint pain and sore in bed.
Almost immediately after receiving the vaccine, I felt a headache, throat scratchiness, numbness to fingers on right hand and discomfort at injection site. Within 2 hours, I could not continue to work and went home. Took motrin at home and rested.  The following morning  the headache was mild but the injection site was very painful. No reddness or swelling, not firm but extremely tender to touch. Pain at injection site was present for 2 days then resolved slowly..
Patient received five different vaccines on 10/26/10.  By noon on 10/27/10 had a fever of 100.0 and a headache and was sent home from school.  Mom call me in the morning of 10/28/10 to report fever and headache continuing and Mom continuing to give patient Tylenol and fever decreased and headache improved while on medication.  I discussed this as side effects of vaccines given and discussed symptoms to report to MD.  I also gave the Mom the website for the Vaccine Information Statements to review the side effects as she had left those in the waiting room after her daughter had received the vaccines.  Mom declined my offer to call on 10/29/10 stating she would call back if symptoms worsened.  No follow-up call from Mom.
Severe pain at injection site, unable to raise arm above 90 degrees of shoulder flexion without the assistance of the opposite arm.
3/28/23 I had increased blood pressure, Atrial Fibrillation, chest pains and an irregular heartbeat. On 3/30/23 I saw my doctor. I had an EKG and an X-Ray, both were clear. She prescribed losartan. I had bloodwork done on 4/4/23 which was unremarkable, normal.